Skip to main content
On this page

    About this guidance

    This guidance outlines the Victorian best practice approach/recommendations for preventing surgical site infection (SSI) and enhancing outcomes following colorectal surgery. It will help perioperative colorectal teams to employ evidence-based best practice in colorectal surgery to optimise patient outcomes. 

    The development of this clinical guideline was a collaboration between Safer Care Victoria, Victorian Healthcare-associated infection surveillance (VICNISS), and other subject matter experts including colorectal surgeons, anaesthetists, enhanced recovery after surgery (ERAS) co-ordinators and infection preventionists.

    Download this guidance

    Aim

    The aim of this clinical guideline is the standardisation of practice and subsequent reduction in SSIs complications following colorectal surgery across health services delivering major colorectal surgery in Victoria.

    This document details: 

    • A bundle of care to be delivered before, during and after surgery aimed at reducing surgical site infection. The elements of the bundle which are evidence-based to reduce SSI have been graded as core (Table 1) and conditional (Table 2). 
    • Essential ERAS items that promote enhanced recovery after surgery but are not targeted at reducing surgical site infection are listed in Table 3 for reference.
    • These recommendations are based on consensus achieved in a modified Delphi process / Nominal Group Technique involving an Expert Advisory Group (Appendix A). Although the process did not involve a systematic formal review of the evidence, international recommendations (e.g. WHO) were reviewed as part of guideline development and the evidence has been accordingly cited. 

    It does not include:

    • Detailed recommendations for risk mitigation practices pre-admission and prehabilitation.
    • This guideline is intended for adult patients. 

    Background

    Colorectal surgery has one of the highest rates of postoperative surgical site infection (SSI), with published rates ranging from 15% to over 30%. 1-4 Surgical Site Infection includes superficial and deep wound infections, and deeper organ space infection within the pelvis, peritoneal cavity and retroperitoneum. Left-sided colonic resections and rectal resections in particular have a higher incidence of postoperative SSI compared with right-sided colonic resections. The consequence of SSIs is increased discomfort for patients in terms of wound discharge and breakdown, readmission to hospital often with a requirement for interventional radiology to drain infections or reoperation. 5,6 Recovery from surgery is prolonged and may involve complex wound dressings and drainage bags. The literature reports that 60% of these SSI outcomes can be prevented through the increased use of evidence-based measures.7

    The need for standardised bundles of care

    The enhanced recovery after surgery (ERAS) study group collaboration was established in 2000 in response to a lack of congruence in perioperative care across sites, unsatisfactory recovery rates, and diverse quality in terms of reporting outcomes. The first ERAS guideline in colorectal surgery was published in 2005, and more recent iterations present a consensus for optimal perioperative care in colorectal surgery and providing graded recommendations for each ERAS item within the ERAS protocol according to the GRADE-system. 8,9

    When comparing ERAS protocols with traditional care in colorectal surgery, ERAS significantly reduces the risk for postoperative morbidity by 48% and median length of stay in hospital by 2.5 days. 9,10 Importantly, current evidence in support of the ERAS protocol applies to the whole protocol and not for every single item within it as the evidence base behind each item within the protocol is constantly changing depending on newly published evidence. 9

    Similarly, there is mounting evidence that implementation of prevention bundles of care is associated with a reduced rate of SSI, particularly deep and organ space SSI after elective colorectal surgery. Implementation of colorectal SSI bundles increases standardisation among surgical teams and decreases operative variance that then leads to reductions in SSIs and an improvement in surgical quality of care. 11

    The earliest SSI prevention bundle, the Surgical Care Improvement Project (SCIP) bundle, 5 was responsible for an 18% decrease in the odds of developing an SSI and a 4% cumulative decrease in SSI rates. 12 The SCIP bundle consisted of elements including intravenous (IV) antimicrobial prophylaxis consistent with published guidelines, hair removal with clippers instead of razors, blood glucose control, and maintenance of preoperative normothermia. 5 More contemporary bundles consist of additional pre-admission, pre-operative, intra and post-operative elements, several of which are specific to colorectal procedures. These include the use of wound protectors, glove changes, and a clean instrument tray for wound closure. 13,14

    A meta-analysis of 23 studies with pre- and post-implementation data published in 2017 evaluated colorectal surgery SSI prevention bundles. They identified an SSI risk reduction of 44% for superficial SSI, and 34% for organ space SSI with the use of bundles. Bundles with sterile closure trays, mechanical bowel preparation (MBP) with oral antibiotics, and pre-closure glove changes had significantly greater SSI risk reduction. 15 A supplementary analysis focusing on bundle size found that bundles with more than 11 components were responsible for a risk reduction of 63.3%, and these optimal bundles included at least 1 of sterile closure trays, MBP with oral antibiotics, and pre-closure glove changes. 16 A multimodal bundle, enhanced and amended over years, including application of a stoma bag prior to dressing (if applied) and 5-day padded Tegaderm dressing, significantly reduced SSI in Scotland. 17 Most recently, a systematic review also found that bundles containing ≥11 elements, consisting of both standard of care and new interventions, demonstrated the greatest SSI reduction following colorectal surgery. 18

    Locally, a study of patients undergoing elective left-sided colorectal procedures at Western Health implemented a bundle including 12 components and demonstrated a reduction in organ space SSI from 12.9% to 3.4%. 19 Notably, all recent bundles include pre-operative oral antibiotics which are associated with a significant reduction in the risk of surgical site infections compared with no pre-operative oral antibiotics even without mechanical bowel preparation. 20-22 Importantly, combined pre-operative oral antibiotics and intravenous antibiotics for surgical antimicrobial prophylaxis are superior to either alone in preventing SSI, 23 and MBP with oral antibiotics is preferable to MBP alone when MBP is used. 

    Evidence for gender differences in patients undergoing ERAS programs associated with colorectal surgery are limited. There is no current evidence in support of providing different ERAS bundles for males and females, nor does gender influence adherence to the prescribed ERAS bundle of care. However, studies of colorectal outcomes suggest that men have a higher risk of SSI (20-45%), whilst women tend to experience a faster recovery and shorter length of hospital stay. One study has also found that female surgeons are more likely to consistently use all ERAS elements. Despite differences in SSI risk and speed of recovery, both genders benefit proportionately from colorectal ERAS programs. 24,25

    Recommended SSI prevention bundle for victorian colorectal surgery programs

    Pre-Admission

    All patients undergoing major colorectal surgery should be screened for modifiable risk factors. 

    Some of these modifiable risk factors will impact upon SSI risk, for example:

    • Smoking cessation
    • Cessation of high alcohol intake, ideally 4 weeks prior to surgery
    • Enhancing diabetes control (HbA1C <7%)
    • Correction of malnutrition
    • Correction of anaemia and iron deficiency
    • Infection control screening
    • Obesity
    • Comorbid disease management

    The time available before surgery to optimise risk factors and offer prehabilitation will vary according to the clinical presentation, and the urgency of the planned management of colorectal pathology. The earlier a patient requiring major colorectal surgery, particularly the higher risk patient, is referred to a high-risk clinic for assessment, the longer the time available to modify risk factors and enable the patient to prepare for their surgery. Ideally, patients likely to require major colorectal surgery should be referred at diagnosis, rather than awaiting the decision of a multidisciplinary meeting or scheduling for surgery. The in-patient admission process should include relevant questions to identify patients at risk of colonisation with multidrug-resistant organisms who may require pre-emptive isolation and screening. 26

    Peri-operative Bundles of Care

    The tables below outline the recommended bundle elements before, during and after surgery. Core elements for SSI prevention, defined as those where there is confidence that the benefits of the intervention outweigh the risks, are presented in table 1. Conditional elements for SSI prevention, those where the benefits of the intervention probably outweigh the risks, are displayed in table 2. 27 Table 3 includes ERAS elements for enhanced recovery. 

    Compliance of ≥80% with bundle elements is recommended. 28

    At the individual health service level, assessment of compliance with individual bundle elements is strongly recommended. 

    Explanatory notes have been provided to assist with local implementation. 

     

    Table 1 Core elements for SSI prevention
    Bundle ElementsCore elements for SSI preventionExplanatory Notes & Considerations for implementation
    Before Surgery

    Oral antibiotics: neomycin & metronidazole

    If neomycin unavailable, use trimethoprim/sulfamethoxazole & metronidazole

    Patients should be prescribed oral neomycin 1g & metronidazole 400mg at 4-hour intervals (for example, 2-3 p.m., 6-7 p.m. and 10-11 p.m.) on the day prior to surgery (total dose: neomycin 3g and metronidazole 1.2g)

    Trimethoprim/sulfamethoxazole 160mg/800mg should be prescribed at 6 a.m. on the day of surgery for morning cases and at 11 a.m. for afternoon cases.

    +/- Mechanical Bowel Preparation (MBP) 
    Pre-warming 
    Hair removal with clippers (single-use head) 
    During Surgery and anaesthesiaDiscussion of bundle during team time out (surgical safety checklist) 
    Skin preparation 2% chlorhexidine in 70% alcohol 
    Pre-incision intravenous surgical antimicrobial prophylaxis

    Cephazolin 2g (3 g if >120kg) should be administered intravenously within 60 minutes before skin incision.

    Metronidazole 500mg should be administered intravenously within 120 minutes before skin incision. 

    For prolonged surgery or significant blood loss IV antibiotic doses must be repeated during surgery: every 4 hours for cefazolin, every 12 hours for metronidazole. 

    If severe penicillin allergy use gentamicin & metronidazole 

    Routine postoperative antibiotics are not recommended. 

    Use of or changing to a level 3 gown where the operation is partly or completely openLevel 3 gowns provide moderate fluid protection and water resistance. They are resistant to water spray and offer some resistance to water penetration under constant contact with increasing pressure. 

    Wound protector

     

     
    Intraoperative warmingIntraoperative warm normal saline peritoneal washout recommended in the Oxford bundle.
    2 separate linear staplers for side-to-side anastomoses 
    Glove change before wound closureGlove change by the whole scrub team prior to incision/closure are recommended in the Oxford bundle.
    Quarantine of contaminated instruments on separate trolley 

    Provide new instruments for wound closure either by using a specific closing tray or by separating closing instruments to a protected area at the start of the case

     

     
    Maintain euglycaemia (6-10)A tighter range should be considered for Type 1 diabetics
    After SurgeryMaintain euglycaemia (6-10)A tighter range should be considered for Type 1 diabetics
    Remove IDC by Day 1 in colon surgery, by Day 2 in rectal surgery 

     

    Table 2 – Conditional elements for SSI preventionh
    Bundle elementsConditional elements for SSI prevention Explanatory Notes
    Before Surgery

    Surgeons should consider the relative benefits of MBP in each case.

     

    MBP with oral antibiotics is preferable to MBP alone when MBP is used.

    MBP may be utilised for reasons unrelated to prevention of SSI.

     

     

     

     Hair removal should be conducted before entering the operating room. 
    During Surgery and anaesthesiaLaparoscopic/minimally invasive/robotic approaches should be used whenever feasible in preference to an open approach 
     Re-draping before closure 
     Gown change before wound closure 
     Irrigation of the superficial layers of the incision with aqueous povidone iodine 
     Closure of the incision in layers, including subcuticular closure (no staples to skin) 
     Wounds closed and dressings applied prior to opening the bowel to create the stoma 
    After SurgeryOcclusive dressing (5 days) 

     

    Table 3 – ERAS elements for enhanced recovery
    Bundle elementsERAS elementsExplanatory Notes & Considerations for implementation
    Before SurgeryImmunonutritionImmunonutrition should be given for up to 5 days before surgery to reduce postoperative infectious complications
    Comorbidities should be optimised before surgery and identified for postoperative planning 
    Preadmission education and information should be provided to all patients prior to surgery 
    White (low residue) diet 
    Dex drinks pre-surgeryPreoperative carbohydrate loading (evening before and 2 hours before anaesthesia) may be used to improve insulin sensitivity
    Sip clear fluids until sent to operating theatre (SipTilSend)Statewide Sip Til Send fluid fasting guidance
    Short preoperative fasting (solids until 6 hours, clear fluids until 2 hours before anaesthesia) 
    During Surgery and anaesthesiaLaparoscopic & minimally invasive approaches (when appropriate) 
    Opioid sparing strategies (lidocaine infusion) 
    Avoid epidurals in laparoscopic surgery 
    Goal-directed fluid therapyTo maintain a slightly positive fluid balance on the day of surgery
    CO2 humidification 
    Warmed IV fluids 
    Minimise use of NGT Prophylactic NGT is not recommended after colorectal surgery
    VTE prophylaxisVictorian Guideline for the Prevention of Venous Thromboembolism in Adult Hospitalised Patients
    Minimise use of drains 
    After SurgeryImmunonutrition (5 days after)Immunonutrition should be given for up to 5 days after surgery to reduce postoperative infectious complications
    Early oral nutritionEarly gut feeding, preferably with oral nutritional supplements within 24 hours post-surgery to enhance nutrient intake, shorten hospital stay and restore gut function
    Avoid epidurals >48 hours for open surgery 
    Minimise duration of PCAs 
    Early mobilisation 

    References

    1. Darouiche RO, Wall MJ, Itani KMF, et al (2010) Chlorhexidine alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 362:18–26. doi: 10.1056/NEJMoa0810988
    2. Tanner J, Khan D, Aplin C, et al (2009) Post-discharge surveillance to identify colorectal surgical site infection rates and related costs. J Hosp Infect 72:243–250. doi: 10.1016/j.jhin.2009.03.021 
    3. Hübner M, Diana M, Zanetti G, et al (2011) Surgical site infections in colon surgery: the patient, the procedure, the hospital, and the surgeon. Arch Surg 146:1240–1245. doi: 10.1001/archsurg.2011. 176
    4. Hewitt DB, Tannouri SS, Burkhart RA, et al (2017) Reducing colorectal surgical site infections: a novel, resident-driven, quality 1928 J Gastrointest Surg (2017) 21:1915–1930 initiative. Am J Surg 213:36–42. doi: 10.1016/j.amjsurg.2016.04. 009
    5. Anderson DJ, Podgorny K, Berríos-Torres SI, et al (2014) Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 35:605–627. doi: 10. 1086/676022 
    6. Keenan JE, Speicher PJ, Nussbaum DP, et al (2015) Improving outcomes in colorectal surgery by sequential implementation of multiple standardized care programs. Journal of the American College of Surgeons 221:404–14.e1. doi: 10.1016/j.jamcollsurg. 2015.04.008
    7. Meeks DW, Lally KP, Carrick MM, et al (2011) Compliance with guidelines to prevent surgical site infections: as simple as 1-2-3? Am J Surg 201:76–83. doi: 10.1016/j.amjsurg.2009.07.050
    8. Gustafsson UO, Scott MJ, Hubner M, Nygren J, Demartines N, Francis N, Rockall TA, Young-Fadok TM, Hill AG, Soop M, De Boer HD. Guidelines for perioperative care in elective colorectal surgery: enhanced recovery after surgery (ERAS®) society recommendations: 2018. World journal of surgery. 2019 Mar 15;43:659-95.
    9. ERAS Society https://erassociety.org/specialty/colorectal/.Accessed March 19, 2025
    10. Teeuwen PH, Bleichrodt RP, Strik C, Groenewoud JJ, Brinkert W, Van Laarhoven CJ, Van Goor H, Bremers AJ. Enhanced recovery after surgery (ERAS) versus conventional postoperative care in colorectal surgery. Journal of Gastrointestinal Surgery. 2010 Jan 1;14(1):88-95.
    11. Fischer JE, Weintraub R (2015) Two senior surgeons’ view: prevention of surgical site infection associated with colorectal operations. Am J Surg 209:1107–1110. doi: 10.1016/j.amjsurg.2014.10. 024 
    12. Munday GS, Deveaux P, Roberts H, et al (2014) Impact of implementation of the Surgical Care Improvement Project and future strategies for improving quality in surgery. Am J Surg 208:835– 840. doi: 10.1016/j.amjsurg.2014.05.005
    13. Ban KA, Minei JP, Laronga C, et al (2017) American College of Surgeons and Surgical Infection Society: surgical site infection guidelines, 2016 update. Journal of the American College of Surgeons 224:59–74. doi: 10.1016/j.jamcollsurg.2016.10.029
    14. Andoh AB, Francis AA, Abdulkarim AA, Adesunkanmi AO, Salako AA, Soladoye A, Sheshe AA, Sani A, Lawal AO, Lawal A, Tripathi A. Routine sterile glove and instrument change at the time of abdominal wound closure to prevent surgical site infection (ChEETAh): a pragmatic, cluster-randomised trial in seven low-income and middle-income countries. The Lancet. 2022 Nov 19;400(10365):1767-76.
    15. Zywot A, Lau CS, Fletcher HS, Paul S. Bundles prevent surgical site infections after colorectal surgery: meta-analysis and systematic review. J Gastrointestinal Surg. 2017 ;21(11):1915-30.
    16. Tomsic I, Chaberny IF, Heinze NR, Krauth C, Schock B, von Lengerke T. The role of bundle size for preventing surgical site infections after colorectal surgery: is more better? J Gastrointestinal Surgery. 2018;22:765-6.
    17. Falconer R, Ramsay G, Hudson J, Watson A, Highland Colorectal SSI Group. Reducing surgical site infection rates in colorectal surgery–a quality improvement approach to implementing a comprehensive bundle. Colorectal Disease. 2021 Nov;23(11):2999-3007.
    18. Pop-Vicas AE, Abad C, Baubie K, Osman F, Heise C, Safdar N. Colorectal bundles for surgical site infection prevention: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2020;41(7):805-12.
    19. Faragher I, Tham N, Hong M, Guy S, Yeung J. Implementation of an organ space infection prevention bundle reduces the rate of organ space infection after elective colorectal surgery. BMJ Open Quality. 2021 May 1;10(2):e001278
    20. Basany EE, Solís-Peña A, Pellino G, Kreisler E, Fraccalvieri D, Muinelo-Lorenzo M, Maseda-Díaz O, García-González JM, Santamaría-Olabarrieta M, Codina-Cazador A, Biondo S. Preoperative oral antibiotics and surgical-site infections in colon surgery (ORALEV): a multicentre, single-blind, pragmatic, randomised controlled trial. The lancet Gastroenterology & hepatology. 2020 Aug 1;5(8):729-38.
    21. Cawich SO, Teelucksingh S, Hassranah S, Naraynsingh V. Role of oral antibiotics for prophylaxis against surgical site infections after elective colorectal surgery. World Journal of Gastrointestinal Surgery. 2017 Dec 12;9(12):246.
    22. Cannon JA, Altom LK, Deierhoi RJ, Morris M, Richman JS, Vick CC, Itani KM, Hawn MT. Preoperative oral antibiotics reduce surgical site infection following elective colorectal resections. Diseases of the colon & rectum. 2012 Nov 1;55(11):1160-6. 
    23. Nelson RL, Hassan M, Grant MD. Antibiotic prophylaxis in colorectal surgery: are oral, intravenous or both best and is mechanical bowel preparation necessary?. Techniques in coloproctology. 2020 Dec;24:1233-46.
    24. Calu V, Piriianu C, Miron A, Grigorean VT. Surgical Site Infections in Colorectal Cancer Surgeries: A Systematic Review and Meta-Analysis of the Impact of Surgical Approach and Associated Risk Factors. Life (Basel). 2024 Jul 5;14(7):850. doi: 10.3390/life14070850. PMID: 39063604; PMCID: PMC11278392.
    25. Cai W, Wang L, Wang W, Zhou T. Systematic review and meta-analysis of the risk factors of surgical site infection in patients with colorectal cancer. Transl Cancer Res. 2022 Apr;11(4):857-871. doi: 10.21037/tcr-22-627. PMID: 35571649; PMCID: PMC9091005.
    26. Victorian Department of Health Communicable Diseases Section (2023). Victorian guideline on carbapenemase producing organisms (version 1.1). Victorian Government, 1 Treasury Place, Melbourne, VIC 3000. Retrieved from: https://www.health.vic.gov.au/infectious-diseases/victorian-guideline-on-cpo-for-health-services.
    27. Global guidelines for the prevention of surgical site infection, second edition. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO.
    28. Calderwood MS, Anderson DJ, Bratzler DW, Dellinger EP, Garcia-Houchins S, Maragakis LL, Nyquist AC, Perkins KM, Preas MA, Saiman L, Schaffzin JK, Schweizer M, Yokoe DS, Kaye KS. Strategies to prevent surgical site infections in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2023 May;44(5):695-720. doi: 10.1017/ice.2023.67. Epub 2023 May 4. PMID: 37137483; PMCID: PMC10867741.
    29. Wade RG, Burr NE, McCauley G, Bourke G, Efthimiou O. The comparative efficacy of chlorhexidine gluconate and povidone-iodine antiseptics for the prevention of infection in clean surgery: a systematic review and network meta-analysis. Annals of surgery. 2021 Dec 1;274(6):e481-8.
    30. Khan A, Wong J, Riedel B, Laing E, Beaumont A, Kong J, Warrier S, Heriot A. The Impact of Peri-operative Enteral Immunonutrition on Post-operative Complications in Gastrointestinal Cancer Surgery: A Meta-Analysis. Ann Surg Oncol. 2023 Jun;30(6):3619-3631. doi: 10.1245/s10434-023-13265-1. Epub 2023 Feb 23. PMID: 36820938.
    31. Singh B, Mal G, Kalra RS, Marotta F. Probiotics and Synbiotics in Perioperative Treatments. InProbiotics as Live Biotherapeutics for Veterinary and Human Health, Volume 2: Functional Foods and Post-Genomics 2024 Nov 12 (pp. 411-421). Cham: Springer Nature Switzerland.
    32. Jiang J, Ren F. Effect of probiotics and synbiotics on complications of wound infection after colorectal surgery: A meta‐analysis. International Wound Journal. 2024 Apr;21(4):e14838.
    33. Mason SE, Kinross JM, Hendricks J, Arulampalam TH. Postoperative hypothermia and surgical site infection following peritoneal insufflation with warm, humidified carbon dioxide during laparoscopic colorectal surgery: a cohort study with cost-effectiveness analysis. Surgical endoscopy. 2017 Apr;31:1923-9.
    34. Mahfouz ME, Althobaiti HS, Alqthami AF, Alamri KA, Mahfouz YS, Elashkar MM, Althomali MM, Mahfouz SA. Prevalence of Surgical Site Infection (SSI) and Its Association With Vitamin D Deficiency. Cureus. 2024 Jan;16(1).
    35. Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited; accessed 17 March 2025. https://www.tg.org.au
    36. Bond-Smith G, Butcher L, Soonawalla Z, Leaper D. How to reduce SSI: a new infection reduction bundle for HPB surgery. Journal of Wound Care. 2021 Apr 2;30(4):254-5.
    37. AORN Recommended Practices for Preoperative Patient Skin Antisepsis. In: Burlingame B, Denholm B, Link T, Ogg MJ, Spruce L, Spry C, et al., editors. Guidelines for Perioperative Practice. Denver, CO: AORN, Inc. Published online January 2016, doi: 10.6015/psrp.15.01.043.
    38.  Mangram AJ, Horan TC, Pearson ML et al 1999 Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection American Journal of Infection Control 27 (2) 97–134
    39.  Institute for Healthcare Improvement 2012 How-to guide: Prevent surgical site infections Cambridge, MA IHI Available from: http://www.ihi.org/resources/Pages/Tools/ HowtoGuidePreventSurgicalSiteInfection.aspx 
    40.  Spencer M, Barnden M, Johnson HB, Fauerbach LL, Graham D, Edmiston Jr CE. Perioperative hair removal: A review of best practice and a practice improvement opportunity. Journal of perioperative practice. 2018 Jun;28(6):159-66.
    Was this content helpful to you?